Jane Street’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,887
Closed -$12.1K 10316
2023
Q4
$12.1K Buy
+2,887
New +$21.8K ﹤0.01% 8954
2019
Q2
Sell
-299
Closed -$52K 5904
2019
Q1
$52K Buy
+299
New +$44.6K ﹤0.01% 4827

Other funds holding ASLN

Jane Street's ASLN Position: Q1 2024 in Review

Jane Street sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2024, closing a stake of 2,887 shares — an estimated $12.1K sold.

Jane Street first reported a position in ASLN in Q1 2019 and held it in 2 quarters. The position peaked at $52K in Q1 2019. 22 funds tracked by Wall St. Rank hold ASLN as of Q1 2024.

  • Jane Street reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 2,887 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2024, an estimated $12.1K.
  • Jane Street first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2019 and held it in 2 quarters.
  • Jane Street's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $52K in Q1 2019.
  • 22 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.